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Lead poisoning is a serious hazard for children 
and causes significant biological and neurologic 
damage linked to cognitive and behavioral 
impairment (Bellinger 2008a, 2008b). The 
level of lead exposure has fallen dramatically 
over the past 30 years because the lead content 
has been reduced in gasoline, household paint, 
food canning, industrial emissions, water lead, 
and other sources, and because public health 
and housing initiatives have targeted the prob-
lem. According to the National Health and 
Nutritional Examination Survey (NHANES), 
a population survey administered by the 
Centers for Disease Control and Prevention 
(CDC), the geometric mean for blood lead 
levels (BLLs) for children 1–5 years of age 
fell from 14.9 μg/dL in 1976 to 1.7 μg/dL 
in 2006 (CDC 2007b). The number of chil-
dren 1–5 years of age with BLLs at least 10 μg/
dL has fallen from an estimated 13.5 million 
to 174,000 over the same period (NHANES 
2003–2006). Although the 1- to 5-year age 
grouping is useful for comparison over time, I 
focus on a cohort of children ≤ 6 years of age 
in which there are an estimated 194,000 chil-
dren with BLLs at least 10 μg/dL.
Recent research has indicated that sig-
nificant neurologic damage to children occurs 
even at very low levels of exposure (Bellinger 
2008a, 2008b; Chen et al. 2007; Lanphear 
et al. 2005). Preventing these levels of expo-
sure in young children will require control-
ling a significant and persistent cause of lead 
poisoning: lead paint used in housing before 
its ban in 1978. Although pre-1950 house 
paint has the largest concentration of lead-
based paint hazards, house paint produced 
in 1950–1978 also contains substantial lead 
content. Poor, urban minorities dispropor-
tionately reside in housing units containing 
lead-based paint hazards, creating significant 
inequity in health and neurologic outcomes 
by ethnicity and socioeconomic status (CDC 
2004). Because the costs of lead paint abate-
ment are nontrivial and the removal must 
be done on a unit-by-unit basis (rather than 
imposed at an industry level), there must be 
substantial commitment to further reduce 
lead poisoning among vulnerable children.
A growing body of literature has detailed 
the economic costs and risks of lead poisoning, 
including several analyses summarizing these 
costs and setting them against the estimated 
costs of lead paint hazard control. However, 
recent research has broadened still the scope 
of our understanding of the societal costs of 
lead poisoning. For example, new studies have 
begun to analyze the correlation of lead poi-
soning with crime rates and their associated 
costs, as well as linking early lead exposure 
to adult-onset health problems. In this article 
I aim to comprehensively address the costs 
and benefits of household lead hazard control 
vis-à-vis new discoveries in the medical, psy-
chological, and economic literature. I focus on 
children ≤ 6 years of age, because lead expo-
sure is the highest for this age group, and this 
is the period when lead exposure produces the 
most significant damage. 
In this analysis, I constructed an upper 
and lower bound on the cost-effectiveness of 
strategies to reduce lead exposure. The rea-
soning behind this methodology is that there 
is no single estimate that accurately reflects 
either the costs or benefits of lead hazard con-
trol. On the costs side, the actual expense 
of reducing lead paint hazards in affected 
homes varies with the extent of interventions 
required. On the benefits side, the number of 
children with lead exposure ranges from those 
reported in state child blood lead surveillance 
data to those determined from weighted esti-
mates of national surveys. Although several 
factors could make one extreme or another 
more credible, it is likely that the truth lies 
within this interval.
Incidence of Low-Level 
Childhood Lead Poisoning
Although the attention on lead and children 
historically has focused on BLLs of ≥ 10 μg/
dL, recent evidence suggests that lower lev-
els incur high individual and societal costs. 
Although community, medical, and environ-
mental interventions have generally been ini-
tiated at a BLL of 10 μg/dL, the government 
has found no level of exposure to lead below 
which adverse health effect do not occur 
(CDC 2004). BLLs between 2 and 10 μg/dL 
have been found to cause persistent cognitive 
damage (Bellinger 2008a, 2008b; Binns et al. 
2007; Lanphear et al. 2005), and children 
with BLLs in this range are likely to benefit 
from aggressive intervention. Table 1 com-
pares the composition of children with BLLs 
between 2 and 10 μg/dL with the demo-
graphic patterns of the entire cohort of chil-
dren ≤ 6 years of age in 2006. Given limited 
sample sizes in the data, it is inadvisable to 
independently measure the characteristics of 
the population with levels > 10 μg/dL.
Of the 27.97 million children ≤ 6 years 
of age in the United States in 2006 (U.S. 
Census Bureau 2008), 24.7%, or 6.9 mil-
lion, have BLLs between 2 and 10 μg/dL 
(NHANES 2003–2006). Males, Hispanics, 
African Americans, and children in house-
holds below 200% of the federal poverty line 
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are disproportionately more likely to have 
higher-than-average lead exposures. 
Sources of Lead and Costs of 
Lead Hazard Control
Although bans on leaded gasoline and paint 
have greatly reduced the incidence of danger-
ous lead levels in children, many children are 
still at risk for damaging lead exposure. Lead 
paint and the related dust and chips are the 
leading cause of high lead levels in U.S. chil-
dren (Levin et al. 2008). Nontrivial sources 
of lead poisoning are contributed by lead-
contaminated water, soil, and dust, although 
the condition of lead-based paint is a strong 
predictor of lead in house dust (Lanphear 
et al. 1998). 
Other incidental sources of household lead 
exposure include the manufacture of stained 
glass and glazed pottery, remodeling of homes, 
toys or pottery containing lead-based paints 
(Mid-Atlantic Center for Children’s Health 
and the Environment 2003), certain calcium 
supplements including antacids and infant 
formula (Scelfo and Flegal 2000), and sec-
ondhand smoke (Mannino et al. 2003). Levin 
et al. (2008) document additional sources of 
lead exposure in eating utensils, breast milk, 
chocolate, candy, and other imported foods 
and related packaging. 
Unfortunately, assessing the costs of 
removal of all lead hazards is difficult, so this 
analysis is restricted to the most common 
source of dangerous lead in children’s envi-
ronments: lead-based paint. Although I posit 
an adjustment for this assumption in the final 
sections of this article, this restriction down-
wardly biases the costs estimates, inflating the 
return on investment.
Lead paint in housing. Lead paint was used 
frequently in housing units until its ban in 
1978; occupants of pre-ban houses are at a 
significantly greater risk for lead exposure. For 
these older housing units, the U.S. Department 
of Housing and Urban Development’s (2002) 
lead guidelines list several methods of safely 
controlling the lead hazard possibilities, includ-
ing paint stripping, replacement, encapsula-
tion, and enclosure. Jacobs et al. (2003) present 
a case study in which the costs of improper 
removal of lead-based paint were examined. 
They found the cost of decontamination 
after uncontrolled use of power sanders to be 
$218,320 for a single house, greatly exceeding 
the incremental costs of incorporating lead-
safe work practices into repainting, a cost they 
estimated to be $1,200 for the individual hom-
eowner [in 2006 U.S. dollars (USD)]. 
The  President’s  Task  Force  on 
Environmental Health Risks and Safety 
Risks to Children (2000) estimates the costs 
for two methods of controlling lead-based 
paint hazards. The first is lead hazard screen-
ing and interim controls, estimated to cost 
$1,200 per housing unit. The second method 
is inspection, risk assessment, and full abate-
ment of lead paint, estimated to cost $10,800 
per housing unit. Because of the variation 
in abatement requirements, regional differ-
ences in costs, condition of housing stock, 
and variation in the costs of adequate supervi-
sion and regulation of such work, the costs of 
lead hazard control can best be identified by 
a range rather than a precise estimate. Using 
the lower and upper bound values found in 
the President’s Task Force (2000), it is likely 
that the true cost lies in the range of $1,200–
$10,800 per housing unit. This is line with 
the finding of Korfmacher (2003) that the 
national average cost of making housing lead-
safe is $7,000 per unit. 
According to the U.S. Department of 
Housing and Urban Development (2002), 
38 million U.S. homes have lead paint, of 
which 24 million housing units were deemed 
to have lead hazards in 2000 (Jacobs et al. 
2002). Four million of these homes have 
young children, and 1.2 million houses are 
at significant risk, with low-income fami-
lies and children ≤ 6 years of age. Linearly 
extrapolating predicted reductions in units at 
risk of lead paint hazards from the President’s 
Task Force (2000), 1.02 million homes are 
at significant risk in 2006. Targeting these 
1.02 million homes most in need and using 
the bounds on costs of $1,200–$10,800 per 
housing unit, the estimated cost lies between 
$1.2 billion and $11.0 billion.
Benefits to Reduction
Health care costs. High lead levels can cause 
multiple and irreversible health problems, 
which include learning disabilities, atten-
tion deficit–hyperactivity disorder (ADHD), 
mental retardation, growth stunting, seizures, 
coma, or, at high levels, death. Previous stud-
ies have identified damaging effects of lead on 
the nervous, hematopoietic, endocrine, and 
renal systems (Bernard 2003). 
Treatment for low lead levels entails con-
tinuous monitoring of blood levels and pre-
vention of further exposure, whereas higher 
lead levels require chemical chelation to leach 
lead from the body, an expensive, time-con-
suming, painful, and sometimes dangerous 
procedure. Kemper et al. (1998) have pro-
vided the most comprehensive assessment of 
health care costs. They estimate the cost for 
CDC’s prescribed medical interventions at 
each blood lead range. 
Kemper et al. (1998) estimated costs of 
screening and treatment as follows: venipunc-
ture ($8.57), capillary blood sampling ($4.29), 
lead assay ($23), risk assessment questionnaire 
($2), nurse-only visit ($42), physician visit 
($105), environmental investigation and haz-
ard removal ($440), oral chelation ($332), 
and intravenous chelation ($2,418). These 
costs have been inflated to 2006 USD using 
the overall Consumer Price Index, an argu-
ably conservative estimate of medical inflation 
because medical costs have increased at rates 
significantly higher than general inflation over 
the past decade. As children’s BLLs increase, 
so do their medical costs. Based on the 
assumptions of Kemper et al. (1998) and the 
CDC (2004) recommendations, it is possible 
to estimate the health costs per child given the 
levels of lead found in the population.
Although there is no BLL below which 
adverse health effects have not been observed 
(Bernard 2003; Binns et al. 2007; Brown 
2007), the costs of medical diagnostics, pre-
vention, and treatment for those with BLLs 
< 10 μg/dL are not included in this analysis 
because the medical costs of treating those 
below this CDC intervention level have not 
been fully assessed in the literature. To the 
extent that this omission is substantial, the 
medical benefits to lead hazard control are 
underestimated. This analysis also assumes that 
children who need treatment receive treatment 
immediately. If immediate treatment delays 
future health problems, and thus costs, then 
the medical benefits are again underestimated. 
For children with levels ranging from 
10 to 20 μg/dL, further diagnostic testing is 
required, necessitating venipuncture and a lead 
assay, followed by an additional nurse-only 
visit, for a total cost of $74 per child. For chil-
dren with levels ranging from 20 to 45 μg/dL, 
the CDC (2004) recommends eight visits for 
diagnostic testing, including a nurse follow-up, 
and environmental investigation of the home 
in question, for a total cost of $1,027 per 
child. For children with BLLs of 45–70 μg/dL, 
the recommended regime includes all of the 
above, accompanied by oral chelation, for a 
total cost per child in the range of $1,335. For 
Table 1. Demographics  of  childhood  lead 
  poisoning (%).
     Share of total 
  BLL  population 
Characteristic  2–10 μg/dL  ≤ 6 years of agea
Children ≤ 6 years  24.7  100.0
  of age
Sex
  Male  53.6  51.1
  Female  46.4  48.9
Race
  White, non-Hispanic  47.4  57.9
  Black, non-Hispanic  23.6  13.7
  Hispanic  24.6  21.1
  Other  4.6  7.3
Income (% federal  
  poverty line)
  Up to 200%   60.2  46.4
  200–400%  22.8  29.2
  ≥ 400%  17.1  24.4
Author’s analysis of NHANES (2003–2006). 
aShares of population ≤ 6 years of age by race do not 
match ratios in other data because of differences in sam-
pling and definitions.Gould
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children with levels ≥ 70 μg/dL, oral chelation 
is replaced with intravenous chelation, for a 
total cost of $3,444 per child.
The estimated number of children affected 
in each group is a combination of two sets 
of data: pooled NHANES (2003–2006) and 
state child blood lead surveillance data from 
the National Center for Environmental Health 
(CDC 2007a). Given the relatively low level 
and nonrepresentative nature of state-level 
testing, the 39,526 children with BLLs > 10 
μg/dL (as reported by the states) represent an 
absolute lower bound of prevalence. According 
to analysis of NHANES 2003–2006, 194,227 
children have BLLs > 10 μg/dL. Because small 
sample sizes prevent accurate categorizing of 
children into each subgrouping of BLL, the 
upper bound is extrapolated by applying the 
ratio of confirmed cases in the CDC state-level 
surveillance data (CDC 2007a) to the num-
bers found in the NHANES and applying it to 
each subgroup. For example, because 39,526 is 
20.35% of 194,227, the upper bound of chil-
dren affected in the 10- to 15-μg/dL group is 
24,554 confirmed cases divided by 20.35%, or 
120,656 children. Table 2 reports the health 
care costs and incidence by BLL groupings. 
Summing across groups, the total cost of treat-
ment is between $10.8 and $53.1 million.
The estimated range includes only the 
direct lead treatment costs for children ≤ 6 
years of age. Lead poisoning causes negative 
health effects later in life, such as neurologic 
disorders, adult hypertension, heart disease, 
stroke, kidney malfunction, elevated blood 
pressure, and osteoporosis (Korrick et al. 
2003; Latorre et al. 2003; Muntner et al. 
2005). Many of these conditions are chronic 
illnesses that must be managed throughout 
an individual’s life course with either expen-
sive pharmaceuticals or continual medical 
interventions. The biological effects of lead 
poisoning do not appear to affect all pop-
ulations equally. Mexican-American and 
African-American populations possess a dis-
proportionately strong relationship between 
elevated lead levels and hypertension, among 
other arterial diseases (Muntner et al. 2005).
Social and behavioral costs. The most well-
established area of research on the effects of 
BLLs on children and society centers around 
the relationship between high BLLs and cog-
nitive and behavioral impairment. Even low 
levels of exposure appear to lower children’s 
IQ, which increases the need for enrollment 
in special education services, reduces the like-
lihood of high school and college graduation, 
lowers lifetime earnings (both through educa-
tional and IQ pathways), and greatly increases 
their propensity to engage in violent crimi-
nal activity. In this section I examine each of 
these factors in turn, assessing the evidence 
and determining the costs of lead exposure to 
the individual and society.
IQ and lifetime earnings. A variety of 
studies analyze the effects of high BLLs on 
intellectual function, most frequently quanti-
fied by IQ. Lanphear et al. (2005) have estab-
lished a clear nonlinear, negative relationship 
between IQ and BLL based on pooled inter-
national data. The rate of IQ loss is greatest 
per unit blood lead < 10 μg/dL. 
Data from NHANES (2003–2006) 
and state-level surveillance of lead poison-
ing (CDC 2007a) determine the number 
of children ≤ 6 years of age affected at each 
BLL ≥ 2 μg/dL (Table 3). The average BLL 
for the 2- to 10-μg/dL group is based on the 
NHANES (2003–2006), the average BLL 
for the 10- to 20-μg/dL group is taken at the 
midpoint, assuming a uniform distribution 
of lead levels within the group, and the aver-
age BLL for the ≥ 20-μg/dL group is taken 
at 20 μg/dL. The small sample size does not 
allow for accurate estimates of average levels 
> 10 μg/dL; however, the assumption of the 
minimum is most conservative. Average IQ 
loss per 1 μg/dL is derived from the findings 
of Lanphear et al. (2005), assuming an even 
distribution of IQ loss within each BLL group. 
Total IQ loss is computed for each BLL 
group, summed, and then multiplied by the 
estimated number of children affected. IQ loss 
from elevated BLLs falls between 9.3 and 13.1 
million points. Although these losses have 
severe social and behavioral consequences, 
they also carry a significant financial burden 
of lost lifetime earnings.
Drawing from Salkever (1995), Schwartz 
(1994), and Nevin et al. (2008), I suggest that 
each IQ point loss represents a loss of $17,815 
in present discounted value of lifetime earn-
ings (in 2006 USD). Using the previously 
computed total IQ loss of 9.3–13.1 million 
points, net lifetime earnings loss is calculated 
to fall between $165 and $233 billion for all 
children ≤ 6 years of age in the 2006 cohort. 
This estimate includes the indirect effects of 
lower educational achievement and workforce 
participation in addition to the direct effect of 
lower hourly wages.
With every loss in lifetime earnings comes 
an associated loss in potential tax revenue for 
the government. Korfmacher (2003), using 
the methodology of Grosse et al. (2002), esti-
mates that the state of New York is losing 
nearly $78 million in tax dollars each year 
because of lowered earnings from lead poison-
ing. If we perform the same exercise with a 
15% marginal tax, lost tax revenue from lead 
poisoning is estimated to be $25–$35 billion 
for each cohort of lead-poisoned children.
Special education. Children with high lead 
levels are in need of special education because 
of their slower development, lower educa-
tional success, and related behavioral problems. 
Schwartz (1994) found that 20% of children 
with BLL > 25 μg/dL needed special education. 
He suggests that the needs of these children 
span an average of 3 years, requiring assistance 
from a reading teacher, psychologist, or other 
specialist. Korfmacher (2003) estimated that 
the average annual cost of special education is 
$14,317 per child (inflated to 2006 USD).
Based on the findings of Schwartz (1994), 
the 20% of children with BLLs > 25 μg/dL 
Table 2. Health care costs (2006 USD).a
  Cost of  Lower bound  Upper bound    
Blood lead  recommended   of affected   of affected  Lower bound  Upper bound 
level (µg/dL)  medical action ($)  children (no.)  children (no.)b  cost ($)  cost ($)
10–15  74  24,554  120,656  1,816,996  8,928,552
15–20  74  8,185  40,220  605,690  2,976,305
20–45  1,207  6,347  31,189  7,660,829  37,644,611
45–70  1,335  376  1,848  501,960  2,466,585
> 70  3,444  64  314  220,416  1,083,104
All levels    39,526  194,227  10,805,891  53,099,158
aKemper et al. (1998) provided estimates for the costs of recommended action (inflated to 2006 USD). bThe upper bound 
values are calculated assuming that CDC state-level surveillance confirmed cases represent 20.35% of estimates > 10 μg/dL 
derived from NHANES (2003–2006): 39,536 confirmed cases to 194,227 cases as estimated from NHANES (2003–2006).
Table 3. Lead and IQ.a
  Lower bound  Upper bound  Average  Average  Lower  Upper
  of affected  of affected  BLL per BLL  IQ point loss  bound  bound
BLL (µg/dL)  children (no.)  children (no.)  group (µg/dL)b  per μg/dLc  IQ loss  IQ loss
2–10  5,632,147  7,400,920  3.13  0.513  9,043,482  11,883,583
10–20  32,739  160,876d  ~ 15  0.19  199,053   978,129
≥ 20  6,678  32,815d  ~ 20  0.11  46,946  230,690
Totals          9,289,482  13,092,402
aData for children with BLLs < 10 μg/dL are estimated from CDC NHANES 2003–2006. Data for children > 10 μg/dL are from 
state-level surveillance and assume uniform distribution of cases within each BLL group. Lower and upper bound for 2- to 
10-μg/dL group represents 95% CIs for NHANES estimate. bAverage BLL calculated for 2–10 μg/dL using CDC NHANES 
2003–2006, average BLL for 10–20 μg/dL taken as the midpoint, and average BLL for ≥ 20 μg/dL group uses the most con-
servative lower bound (the floor) for the mean. cData from Lanphear et al. (2005); assume uniform decreases within BLL 
groups. dValues calculated assuming that CDC confirmed cases represent 20.35% of all cases, given that CDC confirmed 
cases represent 20.35% of NHANES estimates for those > 10 μg/dL. Economic benefits of lead hazard control
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is estimated to fall between 693 and 3,404 
children (using the same bounds analysis as 
described previously). Multiplying out these 
factors with the average cost per child for 
3 years of special education, it costs an esti-
mated $30–$146 million for each cohort of 
lead-poisoned children.
In addition to the relationship of reduced 
IQ on lifetime earnings and the additional 
investments required in special education, 
research indicates adverse effects of lead expo-
sure directly on educational achievement and 
children’s readiness for school (Rothstein 
2004). In addition, studies have found signifi-
cant and negative effects of early and minimal 
lead blood exposure on statewide exam scores, 
in the same order of magnitude as the effect 
of poverty (Miranda et al. 2007). 
Elevated BLLs are associated with an 
increased risk of not completing high school 
(Needleman 2004). Cohen et al. (1998) quan-
tified the effects of dropping out of high school 
on lowered lifetime earnings and increased 
criminal activity. Although there may be a 
direct link between elevated lead levels and 
high school completion, this analysis chooses 
to avoid any potential double-  counting and 
assumes that these effects are included indi-
rectly in the earnings and criminal activity dis-
cussions. Excluding the nonmarket benefits of 
education (Haveman and Wolfe 1984) leads 
to an underestimate of the benefits of lead 
hazard control.
Research by Braun et al. (2006) has quan-
tified the long-observed association between 
childhood lead exposure and development of 
ADHD. ADHD is a highly prevalent, lifelong 
psychiatric disorder that places children at an 
increased risk for conduct disorder, antisocial 
behavior, criminal activity, and drug abuse 
(Costello et al. 2003). Prevalence is estimated 
at 3–8% of children ≤ 15 years of age (CDC 
2005). ADHD is managed through a com-
bination of prescription drug therapy and 
counseling sessions for children and more 
severe adult cases. In addition to high life-
long treatment costs, ADHD also extracts 
significant productivity costs for parents of 
ADHD children. Work by Birnbaum (2005) 
finds that the parents of a child with ADHD 
collectively incur approximately $5 billion in 
work and productivity losses.
The total cost of lead-linked ADHD cases 
in the United States is found by computing 
the number of ADHD cases annually linked 
to early lead exposure, extracted from the 
study of Braun et al. (2006). Of the 1.8 mil-
lion ADHD cases in children 4–15 years of 
age, 21.1%, or 290,000, are linked to BLLs 
> 2 μg/dL (Braun et al. 2006). Assuming aver-
age medical treatment costs per child of $565 
for drug and counseling therapy and average 
parental work loss costs of $119 per child, 
lead exposure costs $267 million annually to 
individual families and society. Because the 
costs of medical treatment and work losses 
are likely to increase greatly with the severity 
of the condition, these estimates represent a 
conservative lower bound for the total costs of 
lead-linked ADHD cases.
Behavior and crime. Medical and eco-
nomic research has established a connection 
between early childhood lead exposure and 
future criminal activity, especially of a vio-
lent nature. Bellinger et al. (1994) found that 
increased lead exposure correlates strongly 
with social and emotional dysfunction. 
Needleman et al. (1996) examined school-
children between the ages of 7 and 11 years 
who had a clinical diagnosis of lead poison-
ing at an early age and found worsening of 
behavior patterns as children with high BLLs 
aged. Needleman et al. (2002) indicated that 
adjudicated delinquents are four times more 
likely to have blood lead concentrations > 25 
ppm than nondelinquent adolescents. 
Recent work by Wright et al. (2008) 
examined a cohort of young adults from 
childhood and found a considerably higher 
and significant rate of arrest, particularly for 
violent crimes, among young adults who had 
elevated lead exposures at an early age. These 
clinical findings confirm broader research that 
links lead exposure to antisocial and destruc-
tive behavior, both in humans and animal 
subjects (Canfield et al. 2004; Denno 1990; 
Froehlich et al. 2007; Surkan and Zhang 
2007).
Nevin (2000) finds that the variation in 
childhood gasoline lead exposure from 1941 
to 1986 explains nearly 90% of the variation 
in violent crime rates from 1960 to 1998, and 
that lead paint explains 70% of the variation 
in murder rates from 1900 to 1960. Reyes 
(2002) takes the evidence of a relationship 
between lead poisoning and criminal behavior 
and estimates that the Clean Air Act (U.S. 
Environmental Protection Agency 2009) in 
the 1970s and 1980s accounts for one-third 
of the drop in crime throughout the 1990s.
Both clinical and econometric evidence 
suggest that lowered lead levels will lead to 
lower crime rates. The Federal Bureau of 
Investigation (2006) lists numbers of crimes 
per 100,000 residents, and the U.S. Bureau 
of Justice Statistics (2004) estimates their 
associated direct costs. Using Nevin’s (2006) 
estimate of the annual number of crimes 
that could have been averted with a 1-μg/dL 
reduction in the average preschool blood lead, 
the total direct costs of lead-linked crime can 
be computed. 
A 1-μg/dL reduction in the average pre-
school BLL results in 116,541 fewer bur-
glaries, 2,499 fewer robberies, 53,905 fewer 
aggravated assaults, 4,186 fewer rapes, and 
717 fewer murders (Table 4). The total direct 
cost of lead-linked crimes is approximately 
$1.8 billion, including direct victim costs, 
costs related to the criminal justice system 
through legal proceedings and incarceration, 
and lost earnings to both criminal and victim. 
An additional $11.6 billion is lost in indirect 
costs, which include psychological and physi-
cal damage necessitating medical treatment 
and preventive measures resulting from the 
criminal action. For this conservative analy-
sis, I considered only the direct costs of each 
crime. Although these effects are for only a 
1-μg/dL decrease, complete removal of lead 
hazards would have even larger effects.
The consequences of an antisocial and 
destructive pathology among lead-poisoned 
children are not isolated to criminal activ-
ity alone. Recent research has indicated that 
moderate levels of childhood lead exposure 
can greatly increase an individual’s propensity 
for risk-taking activities. For instance, Lane 
et al. (2008) found that BLLs > 20 μg/dL are 
strongly linked to repeat teenage pregnancies 
and cigarette smoking among low-income 
youth, both of which incur sizeable costs to 
individuals, families, and society.
Discussion
To demonstrate the cost-effectiveness of lead 
hazard control, I summed and compared the 
total benefits and costs of childhood lead level 
reduction. The costs of lead hazard control 
range from $1.2 to $11.0 billion. The ben-
efits to lead hazard control is the sum of the 
costs for medical treatment ($11–$53 bil-
lion), lost earnings ($165–$233 billion), tax 
revenue ($25–$35 billion), special education 
($30–$146 million), lead-linked ADHD cases 
($267 million), and criminal activity ($1.7 
billion), for a total of $192–$270 billion. The 
net benefit of lead hazard control ranges from 
Table 4. Lead and crime.
  All crimes  Lead-linked crimes  Total lead   
  per 100,000  per 100,000   linked  Direct costs  Total direct
Crime  residents (no.)a  residents (no.)b  crimes (no.)  per crime ($)c  costs ($)c
Burglaries  1335.7  38.7  116,541  4,010  467,329,410
Robberies  213.7  0.83  2,499  22,871  57,154,379
Aggravated assaults  352.9  17.9  53,904  20,363  1,097,628,286
Rape  37.6  1.39  4,186  28,415  118,945,567
Murder  8.3  0.238  717  31,110  22,305,512
Totals      177,847    1,763,363,153
aCalculated using crime incidence data from the Federal Bureau of Investigation (2006). bData from Nevin (2006). cData 
from the Bureau of Justice Statistics (2004); inflated to 2006 USD.Gould
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$181 to $269 billion, resulting in a return 
of $17–$221 for each dollar invested in lead 
hazard control (Table 5). 
The estimate of the benefits of controlling 
lead hazards presented in this paper is still 
quite conservative. The absolute lower bound 
of lead prevalence > 10 μg/dL uses state-level 
confirmed cases and excludes many impor-
tant and potentially substantial costs. These 
include health care later in life, neonatal mor-
tality, benefits of lead hazard control on prop-
erty value and energy savings, community 
improvement, lead paint litigation, indirect 
costs to criminal activity, and other intangi-
ble benefits. Similarly, this analysis calculates 
the benefit for one cohort of U.S. children, 
whereas the duration of lead hazard controls 
are likely to endure for ≥ 6 years (Wilson et al. 
2006). Including future cohorts and assessing 
a full lifetime of costs would vastly increase 
the benefit to lead hazard control.
That said, the major source, lead-based 
paint, is by no means the only source of dan-
gerous lead exposures among children. If a 
similar distribution of lead exposures or high 
and low BLLs are found from both lead-based 
paint and other types of lead hazards, a rough 
adjustment for other major sources of lead 
exposures on these benefits decreases the final 
benefit range by 30%, because lead-based 
paint represents about 70% of childhood 
exposure to lead (Levin et al. 2008). This leads 
to a net benefit ranging from $124 to $188 
billion, resulting in a return of $12–$155 for 
each dollar invested in lead paint hazard con-
trol.
Conclusions
Public health and housing policy has been 
slow to address these remaining lead poison-
ing risks, moving incrementally with tar-
geted, more reactive policies. If the cost of 
proactive and universal lead hazard control 
is seen as prohibitive, the costs of inaction 
have proven to be significantly greater. For 
every dollar spent on controlling lead hazards, 
$17–$221 would be returned in health ben-
efits, increased IQ, higher lifetime earnings, 
tax revenue, reduced spending on special edu-
cation, and reduced criminal activity.
To put these results in perspective, it is 
useful to compare these net benefits to an 
intervention commonly understood as 
tremendously cost effective—that of vaccina-
tions. Cost–benefit analyses show that vac-
cination against the most common childhood 
diseases delivers large returns on investment, 
saving between $5.30 and $16.50 in costs for 
every dollar spent on immunizations (Zhou 
et al. 2005). Given the high societal costs of 
inaction, lead hazard control appears to be 
well worth the expense as well.
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